Leveraging Behavioral Economics to Understand and Improve Financial Decision Making Among Vulnerable Older Adults (Discovery)
2 de julio de 2026 actualizado por: Abdelaziz Alsharawy, The University of Texas Health Science Center, Houston
Leveraging Behavioral Economics to Understand and Improve Financial Decision Making Among Vulnerable Older Adults
This study seeks to:
- Identify behavioral preference patterns that characterize older adults vulnerable to financial exploitation.
- Estimate the extent to which biases in decision-making process influence financial decisions among older adults vulnerable to financial exploitation to refine information content and behavioral 'nudge' strategies.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Tipo de estudio
De observación
Inscripción (Estimado)
400
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Abdelaziz Alsharawy, PhD
- Número de teléfono: (713) 500-9000
- Correo electrónico: Abdelaziz.Alsharawy@uth.tmc.edu
Ubicaciones de estudio
-
-
Texas
-
Houston, Texas, Estados Unidos, 77030
- The University of Texas Health Science Center at Houston
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Método de muestreo
Muestra no probabilística
Población de estudio
For online-only participation, 200 older adults (OAs) recruited via Prolific, a crowdsourcing platform.
Those participating in-lab at the Health Decision Science Lab will include 200 OAs recruited from the Houston area (that is, participants who signed up to the study team's SONA system database).
Descripción
Inclusion Criteria:
- Adults over the age of 60
- English speakers, to ensure comprehension of study tasks
Exclusion Criteria:
- Less than age 60
- Non-English speaker
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
Older Adults who are less vulnerable to financial exploitation
Vulnerability to financial exploitation will be assessed via the Financial Exploitation Vulnerability Scale (FEVS) assessment.
|
|
Older Adults who are more vulnerable to financial exploitation
Vulnerability to financial exploitation will be assessed via the Financial Exploitation Vulnerability Scale (FEVS) assessment.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Frequency of choosing the riskier option on the risk tolerance decision-making task
Periodo de tiempo: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize risk tolerance (willingness to accept uncertain outcomes).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the more trusting option on the trust decision-making task
Periodo de tiempo: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize interpersonal trust (willingness to accept being vulnerable to other people).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the more altruistic option on the altruism decision-making task
Periodo de tiempo: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize altruism (willingness to incur a financial cost to benefit another person).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the more patient option on the impatience decision-making task
Periodo de tiempo: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize patience (willingness to forego a sooner reward for a bigger future reward).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the less loss-averse option on the loss-aversion decision-making task
Periodo de tiempo: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize loss aversion (tendency to weigh potential losses more heavily than equivalent gains).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Physiological arousal as measured via heart rate
Periodo de tiempo: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Physiological arousal as measured via skin conductance
Periodo de tiempo: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Physiological arousal as measured via pupil dilation
Periodo de tiempo: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Frequency of facial expressions associated with valence and engagement
Periodo de tiempo: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
Facial expressions will be assessed using a facial expression analysis system (iMotions software).
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Attention as assessed by eye fixations
Periodo de tiempo: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
Relative fixation duration on each option in the behavioral tasks will be measured via an eye tracker (SmartEye).
|
During the time of the decision-making tasks (about 20-40 minutes)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Response time during the behavioral tasks
Periodo de tiempo: During the time of the decision-making tasks (about 20-40 minutes)
|
Response time will be reported as the time from stimulus presentation to choice, in milliseconds.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Colaboradores
Investigadores
- Investigador principal: Abdelaziz Alsharawy, PhD, The University of Texas Health Science Center, Houston
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
1 de agosto de 2026
Finalización primaria (Estimado)
1 de diciembre de 2027
Finalización del estudio (Estimado)
1 de diciembre de 2027
Fechas de registro del estudio
Enviado por primera vez
26 de junio de 2026
Primero enviado que cumplió con los criterios de control de calidad
26 de junio de 2026
Publicado por primera vez (Actual)
6 de julio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
7 de julio de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
2 de julio de 2026
Última verificación
1 de julio de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- HSC-SPH-25-0344 (Discovery)
- P30AG086563 (Subvención/contrato del NIH de EE. UU.)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .